DOI: 10.1055/s-00000054

Pharmacopsychiatry

Referenz

Kishi T, Mukai T, Matsuda Y. et al.
Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: A meta-analysis of double-blind randomized placebo-controlled trials.

J Psychiatr Res 2013;
47: 1557-1563

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: